Nothing Special   »   [go: up one dir, main page]

UA70302U - Method for evaluation of liver functional state in experiment - Google Patents

Method for evaluation of liver functional state in experiment

Info

Publication number
UA70302U
UA70302U UAU201112597U UAU201112597U UA70302U UA 70302 U UA70302 U UA 70302U UA U201112597 U UAU201112597 U UA U201112597U UA U201112597 U UAU201112597 U UA U201112597U UA 70302 U UA70302 U UA 70302U
Authority
UA
Ukraine
Prior art keywords
experiment
evaluation
functional state
liver
liver functional
Prior art date
Application number
UAU201112597U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Валентин Йосифович Кресюн
Владлена Владимировна Годован
Олег Львович Тымчишын
Дмитрий Юрьевич Андронов
Original Assignee
Одесский Национальный Медицинский Университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Одесский Национальный Медицинский Университет filed Critical Одесский Национальный Медицинский Университет
Priority to UAU201112597U priority Critical patent/UA70302U/en
Publication of UA70302U publication Critical patent/UA70302U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for evaluation of liver functional state in experiment using LCS-metry. As the investigated material homogenate of liver tissue of experimental animals is used, which is centrifugated within 25-30 min at 7000 rpm at 0-4 ° C, after which the resulting supernatant in the amount of 0.2 ml is subjected to investigation by LCS and by increasing the contribution into light scattering of particles having large, from 96 to 264 nm, and extralarge, more than 264 nm size, the conclusion is made about disorder of liver disfunction.
UAU201112597U 2011-10-27 2011-10-27 Method for evaluation of liver functional state in experiment UA70302U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201112597U UA70302U (en) 2011-10-27 2011-10-27 Method for evaluation of liver functional state in experiment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201112597U UA70302U (en) 2011-10-27 2011-10-27 Method for evaluation of liver functional state in experiment

Publications (1)

Publication Number Publication Date
UA70302U true UA70302U (en) 2012-06-11

Family

ID=50847154

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201112597U UA70302U (en) 2011-10-27 2011-10-27 Method for evaluation of liver functional state in experiment

Country Status (1)

Country Link
UA (1) UA70302U (en)

Similar Documents

Publication Publication Date Title
MX2016003660A (en) Virus-like particle conjugates for diagnosis and treatment of tumors.
CY1122278T1 (en) ANTI IL-36R ANTIBODIES
AU2012229123A8 (en) Methods of treating breast cancer with anthracycline therapy
NZ598791A (en) Anti-gcc antibody molecules and related compositions and methods
WO2013082440A3 (en) Methods of treating breast cancer with taxane therapy
EA201300978A1 (en) ANTIBODIES TO CEA
EP4124624A3 (en) Antibodies against canine pd-1
MX348495B (en) Methods and compositions for weed control.
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
EA201790882A1 (en) METHODS AND COMPOSITIONS FOR LIVER CANCER THERAPY
EA201490717A1 (en) ANTIBODIES TO ErbB3 AND THEIR APPLICATION
MX338932B (en) Cd37-binding molecules and immunoconjugates thereof.
WO2014145159A3 (en) Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use
AU2016219704A1 (en) Anti-Notch1 antibodies
MX344521B (en) Heterocycle amines and uses thereof.
TN2012000511A1 (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
ECSP13012673A (en) METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY FOR NEURAL DISEASE
CY1122773T1 (en) USE OF (1R,5S)-(+)-1-(NAPHTHALEN-2-YL)-3-AZADICYCLO{3.1.0.}HEXANE IN THE TREATMENT OF DISEASES AFFECTED BY MONOAMINE NEUROTRANSMITTERS
GB201109238D0 (en) Antibodies
EA201691020A1 (en) METHODS OF TREATMENT AND PREVENTION OF CALLED ALLOGEN ANTIBODIES OF CHRONIC DISEASE "TRANSPLANTAT AGAINST THE OWNER"
MX2014001766A (en) Neuregulin antibodies and uses thereof.
UA107836C2 (en) ALZHEIMER'S DISEASE METHOD
SG10201806454RA (en) Anti-tenascin c antibodies and uses thereof
EA201301264A1 (en) METHOD OF OBTAINING INORGANIC MATERIAL IN THE FORM OF PARTICLES
MX357166B (en) Antibodies to notum pectinacetylesterase.